AB3A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sarepta Therapeutics Inc

Watchlist Manager

Watchlist

Price: 19.48 EUR 5.3% Market Closed

Market Cap: €1.2B

S	Sarepta Therapeutics Inc SWB:AB3A	US
N	National Beverage Corp F:20V	US
	Amper SA F:APR	ES
	Merdeka Copper Gold Tbk PT IDX:MDKA	ID
W	Waste Management Inc F:UWS	US
M	Medtronic PLC XBER:2M6	IE
	Birlasoft Ltd NSE:BSOFT	IN
	OUTsurance Group Ltd F:RMQ0	ZA
T	Tsakos Energy Navigation Ltd F:TK41	GR
H	Haier Smart Home Co Ltd SWB:690D	CN

Profitability Summary

Sarepta Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

85% > 70%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-11%

Operating Margin is Increasing

-60% > -1%

Low Net Margin

Negative 3Y Average Net Margin

-19%

Net Margin is Increasing

-114% > 3%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-30%

Free Cash Flow Margin is Increasing

-48% > 5%

Low ROE

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-58% > -2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

85% > 70%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-11%

Operating Margin is Increasing

-60% > -1%